Ciccone V - Search Results

1

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer.

Moro M, Balestrero FC, Colombo G, Torretta S, Clemente N, Ciccone V, Del Grosso E, Donnini S, Travelli C, Condorelli F, Sangaletti S, Genazzani AA, Grolla AA. Moro M, et al. Among authors: ciccone v. Angiogenesis. 2024 Dec 5;28(1):4. doi: 10.1007/s10456-024-09956-2. Angiogenesis. 2024. PMID: 39636369

2

ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade.

Ciccone V, Terzuoli E, Ristori E, Filippelli A, Ziche M, Morbidelli L, Donnini S. Ciccone V, et al. Int J Mol Med. 2022 Jul;50(1):99. doi: 10.3892/ijmm.2022.5155. Epub 2022 Jun 3. Int J Mol Med. 2022. PMID: 35656893 Free PMC article.

3

Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis?

Filippelli A, Del Gaudio C, Simonis V, Ciccone V, Spini A, Donnini S. Filippelli A, et al. Among authors: ciccone v. Int J Mol Sci. 2022 Nov 2;23(21):13401. doi: 10.3390/ijms232113401. Int J Mol Sci. 2022. PMID: 36362186 Free PMC article. Review.

4

Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.

Ciccone V, Terzuoli E, Donnini S, Giachetti A, Morbidelli L, Ziche M. Ciccone V, et al. J Exp Clin Cancer Res. 2018 Dec 12;37(1):311. doi: 10.1186/s13046-018-0975-0. J Exp Clin Cancer Res. 2018. PMID: 30541574 Free PMC article.

5

Molecular Mechanisms of Resistance to Anti-Angiogenic Drugs.

Filippelli A, Ciccone V, Donnini S, Ziche M, Morbidelli L. Filippelli A, et al. Among authors: ciccone v. Crit Rev Oncog. 2021;26(2):39-66. doi: 10.1615/CritRevOncog.2020035422. Crit Rev Oncog. 2021. PMID: 34347972

6

How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance.

Ciccone V, Morbidelli L, Ziche M, Donnini S. Ciccone V, et al. Cancer Drug Resist. 2020 Mar 19;3(1):26-37. doi: 10.20517/cdr.2019.70. eCollection 2020. Cancer Drug Resist. 2020. PMID: 35582039 Free PMC article. Review.

7

ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output.

Terzuoli E, Bellan C, Aversa S, Ciccone V, Morbidelli L, Giachetti A, Donnini S, Ziche M. Terzuoli E, et al. Among authors: ciccone v. Cancers (Basel). 2019 Dec 6;11(12):1963. doi: 10.3390/cancers11121963. Cancers (Basel). 2019. PMID: 31817719 Free PMC article.

8

ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2.

Filippelli A, Ciccone V, Del Gaudio C, Simonis V, Frosini M, Tusa I, Menconi A, Rovida E, Donnini S. Filippelli A, et al. Among authors: ciccone v. Biochim Biophys Acta Mol Cell Res. 2024 Oct;1871(7):119810. doi: 10.1016/j.bbamcr.2024.119810. Epub 2024 Aug 10. Biochim Biophys Acta Mol Cell Res. 2024. PMID: 39128596 Free article.

9

Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies.

Ciccone V, Ziche M, Spini A, Donnini S. Ciccone V, et al. Pharmaceuticals (Basel). 2023 Jun 12;16(6):867. doi: 10.3390/ph16060867. Pharmaceuticals (Basel). 2023. PMID: 37375814 Free PMC article. Review.

10

ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling.

Ciccone V, Simonis V, Del Gaudio C, Cucini C, Ziche M, Morbidelli L, Donnini S. Ciccone V, et al. Biochem Pharmacol. 2024 Jun;224:116252. doi: 10.1016/j.bcp.2024.116252. Epub 2024 May 1. Biochem Pharmacol. 2024. PMID: 38701866 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters